Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07249489
NA

Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Canada

Sponsor: Nanochon, Inc.

View on ClinicalTrials.gov

Summary

The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.

Official title: A First in Human (FIH) Early Feasibility Study (EFS) to Evaluate the Safety and Performance of the Nanochon Chondrograft™ Implant for Re-surfacing of Cartilage Lesions

Key Details

Gender

All

Age Range

22 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2026-02

Completion Date

2027-08

Last Updated

2026-03-18

Healthy Volunteers

No

Interventions

DEVICE

Nanochon Chondrograft

Mini arthrotomy or arthroscopic surgical implantation of the Nanochon Chondrograft

Locations (3)

Fraser Orthopaedic Institute

New Westminster, British Columbia, Canada

University of British Columbia

Vancouver, British Columbia, Canada

Michael Garron Hospital

Toronto, Ontario, Canada